International Consensus Classification of Myeloid Neoplasms and Acute Leukemias: integrating morphologic, clinical, and genomic data
2022 · Blood · 2,486 citations
https://doi.org/10.1182/blood.2022015850
J
Jean‐Jacques Kiladjian
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
757
Papers
28.8K
Citations
71
h-index
268
i10-index
Jean‐Jacques Kiladjian is an academic researcher from Délégation Paris 5. The author has contributed to research in topics: Myeloproliferative Neoplasms: Diagnosis and Treatment & Chronic Myeloid Leukemia Treatments & Acute Myeloid Leukemia Research. The author has an h-index of 71, co-authored 644 publications.
ORCID: 0000-0002-8121-438XPapers by this author
worksBaveno VII – Renewing consensus in portal hypertension
2021 · Journal of Hepatology · 2,388 citations
https://doi.org/10.1016/j.jhep.2021.12.022
Pure Red-Cell Aplasia and Antierythropoietin Antibodies in Patients Treated with Recombinant Erythropoietin
2002 · New England Journal of Medicine · 1,229 citations
https://doi.org/10.1056/nejmoa011931
Pegylated interferon-alfa-2a induces complete hematologic and molecular responses with low toxicity in polycythemia vera
2008 · Blood · 567 citations
https://doi.org/10.1182/blood-2008-03-143537
Philadelphia chromosome-negative classical myeloproliferative neoplasms: revised management recommendations from European LeukemiaNet
2018 · Leukemia · 538 citations
https://doi.org/10.1038/s41375-018-0077-1
Myeloproliferative Neoplasm (MPN) Symptom Assessment Form Total Symptom Score: Prospective International Assessment of an Abbreviated Symptom Burden Scoring System Among Patients With MPNs
2012 · Journal of Clinical Oncology · 444 citations
https://doi.org/10.1200/jco.2012.42.3863
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat